Rhodia tipped to enter battle for Albright with pounds 470m bid
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.RHODIA, the French chemical group, is this week expected to enter the takeover battle for Albright & Wilson, its troubled UK rival, by trumping a pounds 408m cash offer from Albemarle of the US with a bid of around pounds 470m.
Industry sources said Rhodia's top executives were last night finalising details of its offer with its bankers, and an announcement could come as early as today.
The sources said Rhodia, advised by NM Rothschild and Warburg Dillon Read, was likely to pitch its cash counterbid at around 150p per share, a 13 per cent premium to Albemarle's 130p offer. A&W shares closed 2.5p down at 140p.
The Paris-based group, majority-owned by the French drug company Rhone- Poulenc, is hoping that the counter-offer will be enough to sway Phillips & Drew, A&W's largest shareholder. The fund manager, which has a stake of about 24 per cent, last week refused to accept Albemarle's offer despite a recommendation from A&W, where Paul Rocheleau is chief executive.
P&D believes that the US group is not paying enough for A&W, a leading producer of chemicals for detergents and carbonated drinks with yearly sales of over pounds 815m.
The company's sales and share price have been hit hard by the downturn in chemical markets and the strength of sterling, and a number of shareholders and analysts consider Albemarle's offer too low.
P&D's stance was followed by M&G, which has a stake of over 5 per cent. However, Albemarle secured the support of Mercury Asset Management, the UK group's third-largest investor with a 12 per cent stake.
A bid by Rhodia, which last year had sales of over 5.5bn euros (pounds 3.3bn), would not surprise City analysts. The French company has been seen as a possible bidder for A&W since last week when it revealed that it had held preliminary talks with the British company.
Industry experts believe that a link between Rhodia and A&W would yield greater cost savings as both companies produce phosphates for the cleaning and drinks industries.
A Rhodia counteroffer could open the way for other bids, with the US group FMC and a private UK company backed by venture capitalist CVC tipped as potential bidders.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments